Skip to Content

Join the 'Venous Thromboembolism' group to help and get support from people like you.

Venous Thromboembolism News

Testosterone Therapy May Be Linked to Serious Blood Clots

Posted 7 days ago by Drugs.com

WEDNESDAY, Nov. 30, 2016 – Testosterone treatment can increase a man's risk of potentially fatal blood clots, a new study suggests. Researchers found that men taking the male hormone seem to have a 63 percent increased risk of a blood clot forming in a vein, a condition known as venous thromboembolism (VTE). These clots can cause a heart attack, stroke, organ damage or even death, according to the American Heart Association. "Risk peaks rapidly in the first six months of treatment and lasts for about nine months, and fades gradually thereafter," said lead researcher Dr. Carlos Martinez of the Institute for Epidemiology, Statistics and Informatics in Frankfurt, Germany. Millions of American men currently use testosterone pills, gels or injections, hoping that the male hormone will boost their sex drive, stamina and strength. It's been known for a while that the estrogen in birth control ... Read more

Related support groups: Bleeding Disorder, Testosterone, Deep Vein Thrombosis (DVT), AndroGel, Testim, Axiron, Deep Vein Thrombosis, Androderm, Fortesta, Depo-Testosterone, Testopel, Sexual Deviations or Disorders, Hypoactive Sexual Desire Disorder, Testopel Pellets, Venous Thromboembolism, Testim 5 g/packet, Coagulation Defects and Disorders, Delatestryl, Striant, AndroGel 1.25 g/actuation

Excess Weight Linked to Blood Clot Risk in Kids

Posted 22 Jan 2016 by Drugs.com

THURSDAY, Jan. 21, 2016 – Obese children and teens may have an increased risk for blood clots in their veins, called venous thromboembolism (VTE), a new study suggests. "This is important because the incidence of pediatric VTE has increased dramatically over the last 20 years, and childhood obesity remains highly prevalent in the United States," lead study author Dr. Elizabeth Halvorson, assistant professor of pediatrics at Wake Forest Baptist Medical Center in Winston-Salem, N.C., said in a hospital news release. While the study found a connection between obesity in youngsters and blood clots, the research wasn't designed to prove a cause-and-effect relationship. "Our study presents data from a single institution with a relatively small sample size," Halvorson pointed out. "But it does demonstrate an association between obesity and VTE in children, which should be explored further in ... Read more

Related support groups: Obesity, Venous Thromboembolism

Time Spent in the OR May Be Linked to Blood Clots, Study Shows

Posted 3 Dec 2014 by Drugs.com

WEDNESDAY, Dec. 3, 2014 – Longer surgery times may increase a patient's risk of dangerous blood clots, a new study suggests. Blood clots are associated with more than 500,000 hospitalizations and 100,000 deaths a year, according to background information in the study. Researchers analyzed data from more than 1.4 million people who had surgery under general anesthesia at 315 U.S. hospitals between 2005 and 2011. Of those patients, 0.96 percent developed a blood clot after surgery, 0.71 percent developed a deep vein thrombosis (a blood clot in the veins deep in a limb, usually the legs), and 0.33 percent developed a pulmonary embolism, a blood clot that travels to the lungs. Patients who had the longest operations were 1.27 times more likely to develop a blood clot than those who had average-length surgeries. The risk was lowest among patients who had the shortest surgeries, the ... Read more

Related support groups: Thromboembolic Disorder, Venous Thromboembolism

Common Painkillers Tied to Blood Clot Risk, Study Suggests

Posted 24 Sep 2014 by Drugs.com

WEDNESDAY, Sept. 24, 2014 – People who use painkillers called nonsteroidal anti-inflammatory drugs (NSAIDs) – which include aspirin, naproxen (Aleve) and ibuprofen (Advil, Motrin) – may be at increased risk for potentially deadly blood clots, a new study suggests. But the study only showed an association between use of the painkillers and higher clotting risk; it did not prove cause-and-effect. The researchers analyzed the results of six studies involving more than 21,000 cases of a type of blood clot called a venous thromboembolism (VTE). These clots include deep vein thrombosis (a clot in the leg) and pulmonary embolism (a clot in the lungs). Reporting online Sept. 24 in Rheumatology, the analysis found that people who used NSAIDs had an 80 percent higher risk for venous clots. "Our results show a statistically significant increased VTE risk among NSAID users. Why NSAIDs may ... Read more

Related support groups: Aspirin, Ibuprofen, Naproxen, Advil, Deep Vein Thrombosis (DVT), Aleve, Motrin, Pulmonary Embolism, Deep Vein Thrombosis, Naprosyn, Ecotrin, Vioxx, Naprelan '375', Bayer Aspirin, Naprelan, Anaprox, Anaprox-DS, Bufferin, Aspergum, Fasprin

Most Treatments for Blood Clots Appear Safe, Effective

Posted 16 Sep 2014 by Drugs.com

TUESDAY, Sept. 16, 2014 – Almost all the various treatment options for blood clots that form in veins are equally safe and effective, new research shows. In exploring the safety and effectiveness of treatments for such blood clots as deep vein thrombosis or pulmonary embolism (blood clot in a lung), Canadian researchers analyzed outcomes associated with eight blood-thinning options, including unfractionated heparin, low-molecular-weight heparin (LMWH) and fondaparinux in combination with vitamin K antagonists. The investigators also examined LMWH with dabigatran (Pradaxa), edoxaban, rivaroxaban (Xarelto), apixaban (Eliquis), as well as LMWH alone. After examining nearly 50 randomized studies, the researchers found that unfractionated heparin combined with vitamin K antagonist was associated with a higher percentage of recurrent blood clots over the course of three months than the ... Read more

Related support groups: Xarelto, Deep Vein Thrombosis (DVT), Pradaxa, Pulmonary Embolism, Eliquis, Heparin, Deep Vein Thrombosis, Rivaroxaban, Apixaban, Thrombotic/Thromboembolic Disorder, Arixtra, Hep-Pak, Fondaparinux, Dabigatran, Venous Thromboembolism, Heparin Sodium, Pulmonary Thromboembolism, Arixtra 10 mg/dose, Arixtra 7.5 mg/dose, Hep-Pak CVC

FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism

Posted 24 Aug 2014 by Drugs.com

Thursday, August 21, 2014 - Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA) for Eliquis for the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy. Combined, DVT and PE are known as VTE. It is estimated that every year, approximately 900,000 Americans are affected by DVT and PE. “We are pleased that Eliquis is now available as an effective treatment option for DVT and PE,” said Douglas Manion, M.D., Head of Specialty Development, Bristol-Myers Squibb. “Eliquis offers oral dosing, no routine coagulation testing, and does not require the use of a parenteral anticoagulant or bridging during initiation.” “DVT, which may lead to PE, can be a serious medical condition, with PE requiring immediate med ... Read more

Related support groups: Pulmonary Embolism, Eliquis, Deep Vein Thrombosis, Apixaban, Venous Thromboembolism

Urine Test May Help Spot Dangerous Blood Clots

Posted 18 May 2014 by Drugs.com

SUNDAY, May 18, 2014 – Researchers say they've created a simple urine test that detects the presence of dangerous blood clots in the lungs more accurately than the current blood test. The clot typically forms in the leg, where it is called a deep vein thrombosis, but it can break loose and travel to an artery in the lungs. Once lodged there, the clot, now called a pulmonary embolism, can be life-threatening, the researchers noted. "The main advantage of our test is that it is noninvasive and can be developed into a urine dipstick test that could have a rapid turnaround time," said lead researcher Dr. Timothy Fernandes, from the division of pulmonary, critical care and sleep medicine at the University of California, San Diego. "This would be a tremendous boon to patients from the emergency department to the intensive care unit and even to outpatients," he added. The test measures the ... Read more

Related support groups: Diagnosis and Investigation, Venous Thromboembolism

Study Pinpoints Women at Risk for Blood Clots From Pregnancy

Posted 2 Apr 2013 by Drugs.com

TUESDAY, April 2 – Several factors that increase the risk of blood clots in women during or after pregnancy are outlined in a large new study. Women who were older than 35, who were overweight or obese, or who smoked were at somewhat higher risk of developing blood clots during pregnancy. Medical complications such as pre-existing diabetes, varicose veins and inflammatory bowel disease were also associated with increased risk. The findings could help doctors identify at-risk women and take measures to prevent them from developing blood clots, which can be dangerous and potentially deadly if they break free and travel to areas such as the heart, brain or lungs. For the study, researchers analyzed data from nearly 400,000 pregnancies that occurred between 1995 and 2009. Among new mothers, being obese was associated with a fourfold increased risk of developing a blood clot. The risk was ... Read more

Related support groups: Venous Thromboembolism

Daily Aspirin May Help Those at Risk for Recurrent Blood Clots

Posted 5 Nov 2012 by Drugs.com

MONDAY, Nov. 5 – About a quarter of people who experience the dangerous blood clots in the legs or lungs known as venous thromboembolisms (VTEs) develop them for no discernable reason, and most will receive a powerful anti-clotting drug such as warfarin in the months after the clot forms. But what about longer-term care, to ward off a recurrent clot, or events such as heart attack or stroke? A new study suggests that patients who go on low-dose daily aspirin after they are weaned off more powerful anticoagulants can derive real benefit. While this study alone could not show a significant effect for aspirin therapy in preventing a recurrent clot for these patients, it did show a significant lowering of overall cardiovascular risk for such complications as heart attack, stroke, major bleeding or death from any cause. The study was presented Sunday at the American Heart Association's ... Read more

Related support groups: Aspirin, Ecotrin, Bayer Aspirin, Deep Vein Thrombosis - Prophylaxis, Bufferin, Low Dose ASA, Aspergum, Buffered Aspirin, Fasprin, Venous Thromboembolism, Aspirin Low Strength, ZORprin, Sloprin, Easprin, St Joseph Aspirin, Aspir-Low, Halfprin, Buffasal, Entaprin, Therapy Bayer

Rheumatoid Arthritis May Be Linked to More Blood Clots

Posted 2 Oct 2012 by Drugs.com

TUESDAY, Oct. 2 – New research confirms suspicions that people with rheumatoid arthritis are at somewhat higher risk of developing blood clots in their veins in the decade after diagnosis. The risk appears to be greater during hospitalization, as it is within the general population, the Swedish researchers added. The study, published in the Oct. 3 issue of the Journal of the American Medical Association, doesn't prove that rheumatoid arthritis directly increases the likelihood of blood clots. Still, it provides "strong evidence that there is a connection between rheumatoid arthritis and blood clots, and that something related to rheumatoid arthritis – inflammation, treatment, other factors – is increasing the risk of blood clots," said study author Dr. Marie Holmqvist, a postdoctoral researcher at the Karolinska Institute in Stockholm. Rheumatoid arthritis is different from ... Read more

Related support groups: Rheumatoid Arthritis, Pulmonary Embolism, Venous Thromboembolism

Many Suffer Leg, Lung Clots While Hospitalized: CDC

Posted 8 Jun 2012 by Drugs.com

THURSDAY, June 7 – Hospitalization is a major risk factor for a potentially deadly blood clot and increased public health efforts are needed to reduce this risk, a new federal report says. Researchers at the U.S. Centers for Disease Control and Prevention looked at the number of cases of venous thromboembolism among hospital patients in the United States from 2007 to 2009. Venous thromboembolism consists of deep vein thrombosis (a blood clot in a deep vein) and pulmonary embolism (the passage of the clot into the lungs). Most deep vein clots occur in the lower leg or thigh. The investigators found an annual estimated average of more than 547,000 diagnoses of venous thromboembolism among adult hospital patients aged 18 and older. Of these patients, nearly 349,000 had deep vein thrombosis, more than 277,000 had pulmonary embolism, and over 78,000 had both types of clots. The older the ... Read more

Related support groups: Venous Thromboembolism

Aspirin May Prevent Recurrence of Deep Vein Blood Clots

Posted 23 May 2012 by Drugs.com

WEDNESDAY, May 23 – After suffering a type of blood clot called a venous thromboembolism, patients usually take a blood-thinner such as warfarin (Coumadin). But aspirin may do just as well after a period of time, according to a new Italian study. Blood-thinning, or "anticoagulant," therapy is used to prevent another clot, which occurs in about 20 percent of patients. However, extended use of warfarin can increase the risk for bleeding, so researchers wanted to know whether aspirin would be a good alternative after two years of treatment with warfarin. "Aspirin given after a standard course of anticoagulant treatment may reduce recurrence of venous thromboembolism without increasing complications," said lead researcher Dr. Cecilia Becattini, from the Internal and Cardiovascular Medicine and Stroke Unit at the University of Perugia. So aspirin can be an alternative after an initial ... Read more

Related support groups: Aspirin, Ecotrin, Bayer Aspirin, Bufferin, Low Dose ASA, Aspergum, Buffered Aspirin, Fasprin, Venous Thromboembolism, Aspirin Low Strength, ZORprin, Sloprin, Easprin, St Joseph Aspirin, Aspir-Low, Halfprin, Ecpirin, Buffasal, Entaprin, Therapy Bayer

Blood Clot Risk for Outpatients Needs More Attention: Study

Posted 27 Apr 2012 by Drugs.com

FRIDAY, April 27 – People undergoing outpatient surgery should be warned about their risk for dangerous blood clots, according to a new study that finds the risk is higher among groups including, but not limited to, those who are older or obese. The University of Michigan researchers found that one in 84 patients considered high-risk suffers a blood clot after outpatient surgery. More than 60 percent of operations are currently performed as outpatient procedures, according to background information in a university new release. "Outpatient surgery now includes a greater variety of procedures, from plastic surgery to cancer operations and orthopedic surgery, and not all patients are young, healthy individuals," lead study author Dr. Christopher Pannucci, a University of Michigan plastic surgeon, said in the news release. "These data are in stark contrast to provider and patient ... Read more

Related support groups: Surgery, Venous Thromboembolism

New Blood Thinner May Prevent Blood Clots During Cancer Treatment

Posted 15 Feb 2012 by Drugs.com

WEDNESDAY, Feb. 15 – A new blood-thinning medication called semuloparin reduces the risk of blood clots in people undergoing certain cancer treatments, new research shows. When people with cancer are treated with chemotherapy, they have an increased risk of developing blood clots (venous thromboembolism). These clots can be dangerous, and have the potential to cause heart attacks or strokes. This new drug reduced the risk of blood clots by 64 percent, according to the study, which was funded by Sanofi, the drug's manufacturer. Sanofi was also responsible for the analysis of the study's results. Semuloparin, which is not currently approved by the U.S. Food and Drug Administration, didn't appear to increase the risk of excessive bleeding, which can be a side effect of blood thinners. "Thromboembolism and the effects are very significant," said Dr. Stephanie Bernik, chief of surgical ... Read more

Related support groups: Venous Thromboembolism

Cancer Outpatients at Greater Risk for Blood Clots

Posted 13 Dec 2011 by Drugs.com

MONDAY, Dec. 12 – Cancer patients receiving chemotherapy most often develop blood clots after they are discharged from the hospital, according to a large new study. Efforts to prevent this common and potentially life-threatening complication of cancer treatment should focus on outpatients – not those still in the hospital, the researchers said. A blood clot, also called a venous thromboembolism (VTE), is a mass of red blood cells, clotting proteins and platelets that block the flow of blood. Once cancer patients develop one clot, they're much more likely to develop others, according to a news release from the University of Rochester Medical Center. "One in five patients develops blood clots after a cancer diagnosis and we believe that number is rising," study author Dr. Alok Khorana, an associate professor in the James P. Wilmot Cancer Center at URMC, said in the release. After ... Read more

Related support groups: Venous Thromboembolism

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Deep Vein Thrombosis (DVT), Deep Vein Thrombosis, Pulmonary Embolism, Thromboembolic Disorder

Related Drug Support Groups

Eliquis, Fragmin, apixaban, dalteparin, Dextran 40 in 5% Dextrose, LMD with 5% Dextrose, Gentran 40, dextran, low molecular weight, Rheomacrodex, Dextran 40